Clinical Trial Update: Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma [NA]

View source ↗

Summary

An update on an active-not-recruiting MD Anderson clinical trial assessing the feasibility of combining genomics and transcriptomics for patients with lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING